Related Experiment Video
Updated: Dec 19, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Research status and development potential of composite hemostatic materials
Caiyun Zheng1, Qingyan Zeng1, SaHu Pimpi1
1School of Life Sciences, Northwestern Polytechnical University, 127 West Youyi Road, Beilin District, Xi'an Shaanxi, 710072, P. R. China. lutinglixinxin@nwpu.edu.cn.
Bleeding is a serious incident that can occur in people's daily lives or clinics. Bleeding can be caused by accidental trauma, surgery, congenital diseases, or blood disorders caused by drugs. Excessive bleeding in the body can lead to illness or death. Adequate hemostasis is an essential strategy to prevent bleeding to avoid death and is the first step in wound healing. With rapid developments in science and technology, various hemostatic materials have been developed with the hope of enhancing the hemostatic effect by activating different coagulation mechanisms. Some examples are the formation of physical barriers, platelet aggregation, concentration of blood components, and release of clotting factors. The design of composite hemostatic materials should conform to the requirement according to which multiple coagulation mechanisms can be simultaneously activated in order to enhance the hemostatic effect. Combined with the research status of composite hemostatic materials, it has been found that there is still a lack of materials that exhibit high biocompatibility, shape variability, simultaneous usability for both internal and external bleeding, in vivo degradability, ability to camouflage platelets or blood cells, and other clotting-related factors. Therefore, the future development potential and optimization direction for composite hemostatic materials have been proposed through an in-depth discussion on their characteristics and coagulation mechanisms. It is hoped that this review can provide a worthwhile reference for research into hemostatic materials.
Bleeding is a serious incident that can occur in people's daily lives or clinics. Bleeding can be caused by accidental trauma, surgery, congenital diseases, or blood disorders caused by drugs. Excessive bleeding in the body can lead to illness or death. Adequate hemostasis is an essential strategy to prevent bleeding to avoid death and is the first step in wound healing. With rapid developments in science and technology, various hemostatic materials have been developed with the hope of enhancing the hemostatic effect by activating different coagulation mechanisms. Some examples are the formation of physical barriers, platelet aggregation, concentration of blood components, and release of clotting factors. The design of composite hemostatic materials should conform to the requirement according to which multiple coagulation mechanisms can be simultaneously activated in order to enhance the hemostatic effect. Combined with the research status of composite hemostatic materials, it has been found that there is still a lack of materials that exhibit high biocompatibility, shape variability, simultaneous usability for both internal and external bleeding, in vivo degradability, ability to camouflage platelets or blood cells, and other clotting-related factors. Therefore, the future development potential and optimization direction for composite hemostatic materials have been proposed through an in-depth discussion on their characteristics and coagulation mechanisms. It is hoped that this review can provide a worthwhile reference for research into hemostatic materials.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

